Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Medroxyprogesterone Acetate (Farlutin) is a synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
100 mg | 在庫あり | ¥ 13,000 | |||
500 mg | 在庫あり | ¥ 15,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,500 |
説明 | Medroxyprogesterone Acetate (Farlutin) is a synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms. |
In vitro | Medroxyprogesterone acetate (MPA) and progesterone significantly reduced the levels of glutamic acid decarboxylase (GAD) in the hippocampus, while markedly increasing GAD levels in the olfactory cortex. In aged ovariectomized rats, MPA impaired the retention of delayed memory in the swim arm task and exacerbated overnight forgetting in the Morris water maze. |
In vivo | Medroxyprogesterone acetate (MPA) reduces the secretion of IL-6 and PTHrP in human breast cancer cells and downregulates their expression in KTC-2 cells in a dose-dependent manner. In M-1 cells, MPA and dexamethasone increase the promoter-driven luciferase activity of α-ENaC in a dose-dependent fashion, an effect which is not inhibited by Org31710, indicating that MPA's regulation of α-ENaC is independent of the progesterone receptor (PR). Similarly, MPA and dexamethasone upregulate the mRNA of α-ENaC and SGK1 in both M-1 and Madin-Darby canine kidney-C7 cells, whereas progesterone does not exhibit this effect. At 0.1 nM, MPA significantly enhances the in vitro production of specific immunoglobulin G antibodies, an effect that seems to involve the interaction between progesterone and the PRG receptor. MPA also inhibits the enzyme 3-hydroxysteroid dehydrogenase, which is involved in the reversible conversion between THP and DHP, thereby potentially affecting the action of DHP and THP in the brain. |
別名 | Medroxyprogesterone 17-acetate, Provera, Metigestrona, NSC-26386, Farlutin, Medroxyprogesterone (acetate) |
分子量 | 386.52 |
分子式 | C24H34O4 |
CAS No. | 71-58-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10 mg/mL (25.9 mM)
Ethanol: 10 mg/mL (25.9 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Medroxyprogesterone Acetate 71-58-9 Endocrinology/Hormones Metabolism Others Androgen Receptor Progesterone Receptor Estrogen/progestogen Receptor Glucocorticoid Receptor Endogenous Metabolite Medroxyprogesterone 17-acetate Provera Inhibitor NSC26386 Medroxyprogesterone Metigestrona NSC-26386 Farlutin NR3C3 inhibit NSC 26386 Medroxyprogesterone (acetate) inhibitor